A candidate metastasis-associated DNA marker for ductal mammary carcinoma

Breast Cancer Research

Volumn 5, Issue 2, 2003, Pages

  Achary, Patnala Mohan R ^a   Zhao, Hui ^a   Fan, Zuoheng ^a   Gogineni, Swarna ^a   Pulijaal, Venkat R ^a   Herbst, Lawrence ^a   Mahadevia, Panna S ^a   Jones, Joan G ^a   Klinger, Harold P ^a   Vikram, Bhadrasain ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Archival tumor samples; Mammary carcinoma; Metastasis; Molecular markers; Representational difference analysis

Indexed keywords

CELL DNA; GENOMIC DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; DNA; PHOSPHATASE; PTEN PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; CANCER SCREENING; CHROMOSOME 10Q; CHROMOSOME 10Q21; CONTROLLED STUDY; DNA DETERMINATION; DNA MARKER; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; HCC 1937 CELL LINE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PHASE TRANSITION; POLYMERASE CHAIN REACTION; PTEN GENE; RADIATION HYBRID MAPPING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; BREAST TUMOR; CELL CULTURE; CHEMISTRY; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM METASTASIS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RADIATION HYBRID MAPPING; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0037686181     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr571     Document Type: Article

References (28)

1. Lewis BJ, Conry RM: Breast cancer. In: Cecil Textbook of Medicine. Edited by: Bennett J, Plum F. 1992, USA: WB Saunders, 1320-1325.
2. Scorilas A, Yotis J, Gouriotis D, Keramopoulos A, Ampela K, Trangas T, Talieri M: Cathepsin-D and c-erb-B 2 have an additive progostic value for breast cancer patients. Anticancer Res. 1993, 13: 1895-1900.
3. Fisher B, Dignam J, Wolmark N, DeCillis A, Emir B, Wickerham DL, Bryant J, Dimitrov NV, Abramson N, Atkins JN, Shibata H, Deschenes L, Margolese RG: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1997, 89: 1673-1682. 10.1093/jnci/89.22.1673.
4. Callahan R: MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer. Breast Cancer Res Treat. 1996, 39: 33-44.
5. Pignatelli M, Vessey CJ: Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol. 1994, 25: 849-856.
6. Shi YE, Liu YE, Lippman ME, Dickson RB: Progestins and antiprogestins in mammary tumour growth and metastasis. Hum Reprod. 1994, 9: 162-173.
7. Tozawa K, Sakurada S, Kohri K, Okmoto T: Effect of anti-nuclear factor k B reagents in blocking adhesion of human cancer cell to vascular endothelial cells. Cancer Res. 1995, 55: 4162-4167.
8. Bashyam MD: Understanding cancer metastasis: an urgent need for using differential gene expression analysis. Cancer. 2002, 94: 1821-1829. 10.1002/cncr.10362.
9. Steeg PS, de la Rosa A, Flatow U, MacDonald NJ, Benedict M, Leone A: Nm23 and breast cancer metastasis. Breast Cancer Res Treat. 1993, 25: 175-187.
10. Freije JM, MacDonald NJ, Steeg PS: Nm23 and tumour metastasis: basic and translational advances. Biochem Soc Symp. 1998, 63: 261-271.
11. Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL, Weissman BE: Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Mol Carcinogen. 1998, 21: 111-120. 10.1002/(SICI)1098-2744(199802)21:2<111::AID-MC5>3.0.CO;2-Q.
12. Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M: KAI1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res. 2000, 6: 3424-3429.
13. Toh Y, Pencil SD, Nicolson GL: Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene. 1995, 159: 149-154. 10.1016/0378-1119(94)00410-T.
14. Lee JH, Welch DR: Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer. 1997, 71: 1035-1044. 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.0.CO;2-B.
15. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997, 275: 1943-1947. 10.1126/science.275.5308.1943.
16. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997, 15: 356-362.
17. Seraj MJ, Samant RS, Verderame MF, Welch DR: Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 2000, 60: 2764-2769.
18. Lisitsyn NA, Lisitsyn NM, Wigler M: Cloning the differences between two complex genomes. Science. 1993, 259: 951-964.
19. Mukherjee B, Zhao H, Parashar B, Sood BM, Mahadevia PS, Klinger HP, Vikram B, Achary PMR: Microsatellite dinucleotide (T-G) repeat: a candidate marker for breast metastasis. Cancer Detect Prevent. 2003, 68: 1-5.
20. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA: Laser capture microdissection. Science. 1996, 274: 998-1001. 10.1126/science.274.5289.998.
21. Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, Linehan WM, Reid BJ, Wigler MH: Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci USA. 1995, 92: 151-155.
22. [http://www-genome.wi.mit.edu/cgi-bin/contig/rhmapper]
23. Mathew S, Murty VV, Hunziker W, Chaganti RS: Subregional mapping of 13 single-copy genes on the long arm of chromosome 12 by fluorescence in situ hybridization. Genomics. 1992, 14: 775-779.
24. Rao PH, Murty VVVS, Gaidano G, Hauptschein R, Dalla-Favera R, Chaganti RSK: Subregional localization of 20 single-copy loci to chromosome 6 by fluorescence in situ hybridization. Genomics. 1993, 16: 426-430. 10.1006/geno.1993.1206.
25. [http://ncbi.nlm.nih.gov]
26. Lindblom A, Rotstein S, Skoog L, Nordenskjold M, Larsson C: Deletions of chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res. 1993, 53: 3707-3711.
27. O'Connell P, Fischbach K, Hilsenbeck S, Mohsin SK, Fuqua SA, Clark GM, Osborne CK, Allred DC: Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. J Natl Cancer Inst. 1999, 91: 1391-1397. 10.1093/jnci/91.16.1391.
28. Welch DR, Rinker-Schaeffer CW: What defines a useful marker of metastasis in human cancer?. J Natl Cancer Inst. 1999, 91: 1351-1353. 10.1093/jnci/91.16.1351.